The immense biological diversity of plant species in tropical and subtropical regions suggests an almost inexhaustible source of pharmaceutical substances. In this context, close collaboration with local experts is highly important for the success of these research efforts.
Our co-operation contracts are based on the guidelines of the Bio-diversity Agreement of Rio de Janeiro (1992 ), according to the principles of a fair partnership with developing countries.
In several projects we are exploring new paths in plant research, taking local knowledge into account.
The underlying concept includes fair benefit sharing between all the parties involved. Newly identified medicinal plants are subsequently tested with regard to their therapeutic action by means of high performance screening systems.
For the future, we aim at continuing our above average success story and growing accordingly. To accomplish this, our know-how in research, production and marketing of high-quality phytopharmaceuticals has not only to be maintained, but also systematically developed. Only then can we present the decisive therapeutic benefits of our products and successfully extend their use.
On our way there, the results of research done both by ourselves and in cooperation are indispensable. We thereby concentrate on the application fields where we already have sound expertise. Our focus is on indications for the central nervous system and the cardiovascular system.